Paper Details

  1. Home
  2. Paper Details

Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir.

Author: HuangXiaoling, OonHazel H, QuahKathleen Shu En, ReniaLaurent

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Oral antiviral agents nirmatrelvir-ritonavir (NMV/r) and molnupiravir are used for treating mild-to-moderate COVID-19 infection in outpatients. NMV/r, however, has significant drug-drug interactions (DDIs) with commonly prescribed medications. This review summarizes available data on DDIs between NMV/r, molnupiravir, and dermatological medications, highlighting potential side effects and suggesting strategies for safe COVID-19 treatment in the context of emerging variants and widespread use of oral therapies.
Paper Details　
Original Abstract of the Article :
The oral antiviral agents nirmatrelvir-ritonavir (NMV/r) and molnupiravir are used to treat mild-to-moderate COVID-19 infection in outpatients. However, the use of NMV/r is complicated by significant drug-drug interactions (DDIs) with frequently prescribed medications. Healthcare professionals shoul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/36592146

データ提供：米国国立医学図書館（NLM）

Drug Interactions: Navigating the Desert of COVID-19 Treatment

The emergence of COVID-19 has presented a new desert of challenges, with the need for effective treatments. Oral antiviral agents like nirmatrelvir-ritonavir (NMV/r) and molnupiravir offer hope, but they can interact with other medications, creating potential pitfalls along the way. This research reviews potential drug-drug interactions (DDIs) between these antiviral agents and common dermatological medications. The authors highlight the importance of understanding these interactions to ensure safe and effective treatment for patients.

Avoiding Pitfalls: Understanding Drug Interactions

The desert of COVID-19 treatment can be filled with hidden dangers. This research highlights the critical importance of considering potential drug interactions when prescribing NMV/r and molnupiravir. Healthcare professionals must be vigilant in understanding these interactions to avoid potentially dangerous consequences and ensure optimal patient outcomes.

Navigating the Desert of COVID-19 Treatment: A Guide for Safe Passage

Navigating the desert of COVID-19 treatment requires a cautious and informed approach. Understanding potential drug interactions is vital in ensuring a safe and effective journey. Healthcare professionals must carefully consider all medications a patient is taking to minimize the risk of adverse events and promote optimal treatment outcomes.

Dr.Camel's Conclusion

This research underscores the importance of understanding drug interactions in the context of COVID-19 treatment. By recognizing and managing these interactions, healthcare professionals can ensure a safer and more effective journey for patients navigating the desert of COVID-19.

Date :
  1. Date Completed 2023-01-04
  2. Date Revised 2023-01-11
Further Info :

Pubmed ID

36592146

DOI: Digital Object Identifier

36592146

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.